In other cancers, promising prognostic potential of PHD2 has been observed as high PHD2 levels have been reported to be associated with better prognosis at least in gastric cancer, breast cancer, and colorectal cancer.29, 30, 31. This evidence concerns the gene EGLN1 and breast carcinoma.